Marshall Wace
LYRA

Marshall Wace’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Marshall Wace’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-259
Closed -$74K – 3605
2022
Q2 		$74K Buy
+259
New +$70.5K ﹤0.01% 3303
2021
Q4 		– Sell
-249
Closed -$114K – 4122
2021
Q3 		$114K Sell
249
-137
-35% -$51.8K ﹤0.01% 2875
2021
Q2 		$155K Sell
386
-553
-59% -$252K ﹤0.01% 2491
2021
Q1 		$544K Buy
939
+658
+234% +$411K ﹤0.01% 1907
2020
Q4 		$160K Buy
+281
New +$158K ﹤0.01% 1769

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Marshall Wace's LYRA Position: Q3 2022 in Review

Marshall Wace sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2022, closing a stake of 259 shares — an estimated $74K sold.

Marshall Wace first reported a position in LYRA in Q4 2020 and held it in 5 quarters. The position peaked at $544K in Q1 2021. 37 funds tracked by Wall St. Rank hold LYRA as of Q3 2022.

  • Marshall Wace reported no remaining LYRA THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 259 LYRA THERAPEUTICS INC shares in Q3 2022, an estimated $74K.
  • Marshall Wace first reported a position in LYRA THERAPEUTICS INC in Q4 2020 and held it in 5 quarters.
  • Marshall Wace's LYRA THERAPEUTICS INC position peaked at $544K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.